Regulatory
Matters |
|
Antipsychotics |
|
Clopidogrel |
|
Dextropropoxyphene/
propoxyphene-containing medicines |
|
Erlotinib |
|
Immunosuppressant
medicines |
|
Mycophenolate
mofetil |
|
Piroxicam |
|
Varenicline
and bupropion |
|
Zinc-containing
intranasal products |
Safety of Medicines |
|
Cefepime |
|
Chloral
hydrate and triclofos |
|
Fentanyl
transdermal patches |
|
Golimumab |
|
Insulin
glargine |
|
Latanoprost
and rosiglitazone |
|
Leukotriene
inhibitors |
|
Metformin |
|
Omalizumab |
|
Propylthiouracil |
|
Sirolimus |
|
Stimulant
medications |
|
Topical
ketoprofen |
|
Triamcinolone
acetonide |
|
Tumour
necrosis factor inhibitors |
Feature |
|
Inspections
of Bio-Equivalence Studies |